No Data
Econavista: Interim report.
Econavista: Financial Report - 15th Term (2023/11/01 - 2024/10/31)
Econavista: Confirmation letter.
Econavista: Corrected Financial Report - 14th Term (2022/11/01－2023/10/31)
Individual stock information.
Econavista <5585.T> has risen for three consecutive days. It has entered into a business partnership with DFree (Minato-ku, Tokyo), which plans, develops, and sells a defecation prediction device called 'DFree'. As a result, collaboration on the system and sales of DFree's defecation prediction device will begin with the company's SaaS (Software as a Service) type elderly monitoring system service 'Life Rhythm Navi + Dr.'. Groving <277A.T> has rapidly rebounded. February 28 is set as the record date.
Econavista has signed a business partnership agreement with DFree.
Econavista <5585.T> announced on the 23rd that it has signed a business partnership contract with DFree (Minato-ku, Tokyo), which plans, develops, and sells the excretion prediction device "DFree." With this partnership, the company will start system integration and sales collaboration of the SaaS-type elderly monitoring system service "Life Rhythm Navi + Dr." developed based on the provided sleep analysis technology, and DFree's excretion prediction device "DFree." The closing price on the 23rd was 15, up 97 yen from the previous day.